The National Institutes of Health said today that it has launched the first large-scale clinical trial of a long-acting injectable drug for HIV preparation in sexually-active women. The NIH is funding the study in partnership with ViiV Healthcare and the Bill & Melinda Gates Foundation. The study, which is being conducted in southern and eastern […]
FDA approves first two-drug HIV regimen in a single pill
The FDA yesterday approved the first two-drug regimen available in a single pill for the maintenance treatment of HIV. The drug, Juluca, combines ViiV Healthcare‘s integrase strand transfer inhibitor and Janssen Therapeutics‘ non-nucleoside reverse transcriptase inhibitor. The treatment is indicated for adults with HIV who are virologically suppressed on a stable anti-retroviral regimen for at […]
Drug Delivery Business News
@DrugDeliveryNow
LinkedIn